1. Home
  2. ATRA vs SQNS Comparison

ATRA vs SQNS Comparison

Compare ATRA & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRA
  • SQNS
  • Stock Information
  • Founded
  • ATRA 2012
  • SQNS 2003
  • Country
  • ATRA United States
  • SQNS France
  • Employees
  • ATRA N/A
  • SQNS N/A
  • Industry
  • ATRA Biotechnology: Biological Products (No Diagnostic Substances)
  • SQNS Semiconductors
  • Sector
  • ATRA Health Care
  • SQNS Technology
  • Exchange
  • ATRA Nasdaq
  • SQNS Nasdaq
  • Market Cap
  • ATRA 51.1M
  • SQNS 46.5M
  • IPO Year
  • ATRA 2014
  • SQNS 2011
  • Fundamental
  • Price
  • ATRA $11.58
  • SQNS $1.98
  • Analyst Decision
  • ATRA Strong Buy
  • SQNS Strong Buy
  • Analyst Count
  • ATRA 4
  • SQNS 1
  • Target Price
  • ATRA $20.00
  • SQNS $7.50
  • AVG Volume (30 Days)
  • ATRA 57.7K
  • SQNS 11.8M
  • Earning Date
  • ATRA 08-11-2025
  • SQNS 07-31-2025
  • Dividend Yield
  • ATRA N/A
  • SQNS N/A
  • EPS Growth
  • ATRA N/A
  • SQNS N/A
  • EPS
  • ATRA N/A
  • SQNS 2.16
  • Revenue
  • ATRA $199,732,000.00
  • SQNS $38,858,000.00
  • Revenue This Year
  • ATRA N/A
  • SQNS N/A
  • Revenue Next Year
  • ATRA N/A
  • SQNS $83.38
  • P/E Ratio
  • ATRA N/A
  • SQNS $1.00
  • Revenue Growth
  • ATRA 475.53
  • SQNS 40.06
  • 52 Week Low
  • ATRA $5.01
  • SQNS $1.18
  • 52 Week High
  • ATRA $18.71
  • SQNS $5.83
  • Technical
  • Relative Strength Index (RSI)
  • ATRA 66.87
  • SQNS 43.74
  • Support Level
  • ATRA $8.53
  • SQNS $1.34
  • Resistance Level
  • ATRA $13.46
  • SQNS $5.83
  • Average True Range (ATR)
  • ATRA 0.96
  • SQNS 0.87
  • MACD
  • ATRA 0.28
  • SQNS -0.18
  • Stochastic Oscillator
  • ATRA 62.65
  • SQNS 6.33

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

Share on Social Networks: